Patrice X. Petit | Signal Transduction | Best Researcher Award

Published on by NESIN Awards

Dr. Patrice X. Petit | signal transduction | Best Researcher Award

 Research director | Centre National de la Recherche Scientifique | France

Dr. Patrice X. Petit, Doctor ès Sciences and PhD in Biology, is a Research Director at the French National Centre for Scientific Research (CNRS), where he has served since 1979 and established an internationally recognized career in cell biology. Trained at the Université Pierre et Marie Curie and the Université Denis Diderot (Paris), his work has focused on the molecular mechanisms governing cell death, mitochondrial dynamics, oxidative stress, and their implications in cancer biology, immunology, and toxicology. Over more than four decades, he has developed a broad international scientific presence through extensive teaching and research collaborations across Europe, North America, and Asia, including academic engagements with institutions such as the Chinese Academy of Sciences, Caltech, UT Southwestern, the Beatson Cancer Research Center in Glasgow, the University of Madrid, and multiple leading universities throughout Scandinavia, Germany, and France. His scientific leadership is further reflected in his service as an elected member (2016–2020) of the Scientific Council of the CNRS Institute of Biological Sciences (INSB). Dr. Petit has authored 134 scientific publications, accumulating approximately 12,500 citations and an h-index of 44, demonstrating sustained research influence across several biomedical domains, including contributions to plant biology. He is an active peer reviewer for major journals such as Cancer Research, Journal of Cell Biology, PNAS, Oncogene, and Cell Death and Differentiation, and he has served as a grant reviewer for major funding bodies, including the Austrian Academy of Sciences, the French National Research Agency (ANR), EMBO, the Swiss National Science Foundation, and the Fondation pour la Recherche Médicale. His interdisciplinary background—ranging from a formal qualification in history (Université Paris Diderot, 1979) to a DIU in rare diseases (Université de Strasbourg, 2017)—underscores both scientific depth and broader intellectual engagement. Through his sustained research output, international collaborations, and service to the scientific community, Patrice X. Petit has contributed significantly to advancing fundamental and translational knowledge in cell biology, with measurable societal impact across biomedical research and education.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

Zamzami, N., Marchetti, P., Castedo, M., Decaudin, D., Macho, A., Hirsch, T., … Petit, P. X. (1995). Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. The Journal of Experimental Medicine, 182(2), 367–377.

Zamzami, N., Marchetti, P., Castedo, M., Zanin, C., Vayssière, J. L., Petit, P. X., … Kroemer, G. (1995). Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. The Journal of Experimental Medicine, 181(5), 1661–1672.

Kroemer, G., Petit, P., Zamzami, N., Vayssière, J. L., & Mignotte, B. (1995). The biochemistry of programmed cell death. The FASEB Journal, 9(13), 1277–1287.

Petit, P. X., Lecoeur, H., Zorn, E., Dauguet, C., Mignotte, B., & Gougeon, M. L. (1995). Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. The Journal of Cell Biology, 130(1), 157–167.

Petit, P. X., Susin, S. A., Zamzami, N., Mignotte, B., & Kroemer, G. (1996). Mitochondria and programmed cell death: Back to the future. FEBS Letters, 396(1), 7–13.

Dr. Petit’s work has fundamentally advanced our understanding of mitochondrial biology and programmed cell death, shaping modern concepts of apoptosis, autophagy, and cellular stress responses. His discoveries enabled new biomedical approaches to cancer, immunology, and rare diseases

Youngmi Song | Biology | Best Researcher Award

Published on by NESIN Awards
🌟Assoc Prof Dr. Youngmi Song, Kagbuk Samsung Hospital/Medical Research institute, South Korea: Biology🏆
Professional Profiles:
Bio Summary

I am Dr. Youngmi Song, a dedicated researcher with a Ph.D. in Biomedical Science from Yonsei University College of Medicine. Throughout my academic and professional journey, I have contributed significantly to the fields of hepatosteatosis, autophagy, and gut microbiota, among others.

Education
  • Ph.D. in Biomedical Science
    • Period: September 2011 to February 2015
    • Institution: Yonsei University College of Medicine, Seoul, Republic of Korea
Research Focus

My research primarily focuses on understanding and addressing metabolic disorders, with a particular emphasis on hepatosteatosis, nonalcoholic steatohepatitis, and the role of gut microbiota in these conditions. Additionally, I have explored pathways related to autophagy, GLP-1 secretion, and the effects of various pharmacological interventions.

Professional Journey
  • Research Professor
    • Institution: Medical Research Institute, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
    • Period: October 2019 onwards
  • Postdoctoral Fellow
    • Institution: Luenfeld-Tanenbaum Research Institute, Sinai Health System, University of Toronto, Canada
    • Period: April 2016 to 2019
  • Postdoctoral Fellow
    • Institution: Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
    • Period: February 2015 to February 2016
Honors & Awards
  • Academic Award for Highest Achievement
    • Institution: Yonsei University College of Medicine
    • Date: February 2015
  • Travel Grant
    • Event: 9th International Diabetes Federation Western Pacific Region Congress, Kyoto, Japan
    • Date: November 2012
Author Metrics
  • Citations: 825
  • Documents: 11
  • h-index: 10
Publications Top Noted & Contributions

I have made substantial contributions to scientific literature, particularly in prestigious journals, shedding light on topics such as gut microbiota, GLP-1 secretion, hepatosteatosis, and autophagy. Noteworthy publications include studies on Gemigliptin, metformin, and the impact of glycated albumin on pancreatic beta-cell function.

Gemigliptin, a DPP4 inhibitor, ameliorates nonalcoholic steatohepatitis through AMP-activated protein kinase-independent and ULK1-mediated autophagy

  • Journal: Molecular Metabolism (2023)
  • Citations: 0

Intestine-selective reduction of Gcg expression reveals the importance of the distal gut for GLP-1 secretion

  • Journal: Molecular Metabolism (2020)
  • Citations: 37

Gut-Proglucagon-Derived Peptides Are Essential for Regulating Glucose Homeostasis in Mice

  • Journal: Cell Metabolism (2019)
  • Citations: 78

Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition

  • Journal: Autophagy (2017)
  • Citations: 146

Association between betatrophin/ANGPTL8 and non-alcoholic fatty liver disease: Animal and human studies

  • Journal: Scientific Reports (2016)
  • Citations: 76

Metformin restores parkin-mediated mitophagy, suppressed by cytosolic p53

  • Journal: International Journal of Molecular Sciences (2016)
  • Citations: 67

Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway

  • Journal: Autophagy (2015)
  • Citations: 229
Research Timeline
  • 2011-2015: Pursued Ph.D. in Biomedical Science at Yonsei University College of Medicine.
  • 2015-2016: Conducted postdoctoral research on hepatosteatosis and autophagy at Yonsei University College of Medicine.
  • 2016-2019: Engaged in postdoctoral research as a Kangbuk Samsung-BBDC International Research Fellow at the University of Toronto.
  • 2019-Present: Currently serving as a Research Professor at the Medical Research Institute, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, focusing on metabolic disorders.